Issue 56, 2020

Novel copper-based and pH-sensitive nanomedicine for enhanced chemodynamic therapy

Abstract

We utilized albumin as a reducing agent to establish novel copper-based and pH-sensitive nanocarrier CuNPs with abundant Cu+, which can encapsulate histone deacetylase (HDAC) inhibitor vorinostat to form uniform and stable nanomedicine V-CuNPs for synergistic chromatin remodelling and chemodynamic therapy.

Graphical abstract: Novel copper-based and pH-sensitive nanomedicine for enhanced chemodynamic therapy

Supplementary files

Article information

Article type
Communication
Submitted
08 Jan 2020
Accepted
03 Jun 2020
First published
02 Jul 2020

Chem. Commun., 2020,56, 7753-7756

Novel copper-based and pH-sensitive nanomedicine for enhanced chemodynamic therapy

L. Wang, Z. Zhang, Y. Ding, J. Wu, Y. Hu and A. Yuan, Chem. Commun., 2020, 56, 7753 DOI: 10.1039/D0CC00165A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements